Xintela

Xintela EBIT per Share

The EBIT per Share of Xintela (XINT.ST) as of Oct 20, 2026 is -0.06 SEK. In the previous year, EBIT per Share was -0.07 SEK — a change of -18.69% (higher).

EBIT per Share

-0.06SEK

YoY

-18.69%

Last updated:

EBIT per Share of Xintela is 2025 -0.06 SEK. EBIT per Share of Xintela was 2024 -0.07 SEK. It decreases by -18.69% higher compared to the previous year.

The Xintela EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2023
-0.14 SEK
Jan 1, 2024
-0.07 SEK
Jan 1, 2025
-0.06 SEK
Jan 1, 2026 (e)
-0.01 SEK
Jan 1, 2027 (e)
-0.13 SEK
Jan 1, 2028 (e)
-0.06 SEK
Jan 1, 2029 (e)
-0.03 SEK
Jan 1, 2030 (e)
-0.02 SEK
The Xintela EBIT per Share history
YEAREBIT per ShareYoY
est-0.02SEK-27.21%
est-0.03SEK-44.95%
est-0.06SEK-57.42%
est-0.13SEK+836.06%
est-0.01SEK-75.26%
-0.06SEK-18.69%
-0.07SEK-49.53%
-0.14SEK-64.53%
-0.38SEK-7.45%
-0.42SEK-29.50%
-0.59SEK+8.70%
-0.54SEK-27.44%
-0.75SEK+78.76%
-0.42SEK+10.85%
-0.38SEK-42.39%
-0.65SEK+18,723.43%
-0.00SEK+33.88%
-0.00SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Xintela Stock analysis

What does Xintela do? Xintela AB, based in Lund, Skåne, develops pharmaceutical products in the Health Care sector, specifically focusing on regenerative medicine for cartilage damage and osteoarthritis, as well as treatments for glioblastoma brain tumors. The company utilizes therapeutic antibodies and XINMARK, a marker technology using specific proteins to identify stem cells for cartilage development. Listed on 22 March 2016, Xintela operates within biotechnology, targeting innovative therapies in oncology and orthopedics. Xintela is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Xintela stock

EBIT per Share of Xintela is -0.06 SEK in 2025.

EBIT per Share of Xintela changed from -0.07 SEK to -0.06 SEK, representing a -18.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Xintela since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Xintela

All Key Metrics — Xintela